Crossmark

Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells

Crossref DOI link: https://doi.org/10.1186/s12885-018-4522-3

Published Online: 2018-07-18

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jiang, Ke

Song, Cuiping

Kong, Lingkai

Hu, Lulu

Lin, Guibin

Ye, Tian

Yao, Gang

Wang, Yupeng

Chen, Haibo

Cheng, Wei

Barr, Martin P.

Liu, Quentin

Zhang, Guirong

Ding, Chan

Meng, Songshu
Funding

Funding for this research was provided by:

the National Science Foundation of China (81372471, 81502674, 31530074)

the National Science Foundation of Liaoning Province (2015020655)
License Information

Text and Data Mining valid from 2018-07-18
More Information

Article History

Received: 13 October 2017

Accepted: 18 May 2018

First Online: 18 July 2018

Ethics approval and consent to participate

: All animal experiments were conducted at Dalian Medical University (Dalian, China), complying with the national guidelines for the care and use of laboratory animals and were approved by the experimental animal ethics committee at Dalian Medical University.

: The authors have declared that no competing interests exist.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.